Defining the distinct, intrinsic properties of the novel type i interferon, IFNϵ

Journal of Biological Chemistry

Volumn 293, Issue 9, 2018, Pages 3168-3179

  Stifter, Sebastian A ^a,b,h   Matthews, Antony Y ^a,b   Mangan, Niamh E ^a,b   Fung, Ka Yee ^a,b,i   Drew, Alexander ^a,b   Tate, Michelle D ^a,b   Soares Da Costa, Tatiana P ^c   Hampsey, Daniel ^d   Mayall, Jemma ^d   Hansbro, Phil M ^d   Minambres, Albert Garcia ^e,f   Eid, Sahar G ^e,f   Mak, Johnson ^e,f,g   Scoble, Judy ^f   Lovrecz, George ^f   DeWeerd, Nicole A ^a,b   Hertzog, Paul J ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e DEAKIN UNIVERSITY   (Australia)

^f CSIRO   (Australia)

^g GRIFFITH UNIVERSITY   (Australia)

^h CENTENARY INSTITUTE   (Australia)

ⁱ WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CHEMICAL ACTIVATION; GLYCOPROTEINS;

ANTI-BACTERIAL ACTIVITY; ANTIVIRAL ACTIVITIES; FUNCTIONAL CHARACTERIZATION; INTRINSIC ACTIVITIES; INTRINSIC PROPERTY; SIGNALING ACTIVITY; SIGNALING PATHWAYS; TYPE I INTERFERONS;

DISEASES;

ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; ALPHAN1 INTERFERON; BETA INTERFERON; BETA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR 1; EPSILON INTERFERON; INTERFERON; RECOMBINANT EPSILON INTERFERON; STAT1 PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; INTERFERON RECEPTOR;

ALPHA HELIX; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; JAK-STAT SIGNALING; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION; ANIMAL; CELL PROLIFERATION; CHEMISTRY; CHLAMYDIA; DRUG EFFECT; FEMALE; METABOLISM; MUCOSAL IMMUNITY; PHOSPHORYLATION; RAW 264.7 CELL LINE; REPRODUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CELL PROLIFERATION; CHLAMYDIA; FEMALE; HUMANS; IMMUNITY, MUCOSAL; INTERFERON TYPE I; MICE; PHOSPHORYLATION; PROTEIN CONFORMATION, ALPHA-HELICAL; RAW 264.7 CELLS; RECEPTORS, INTERFERON; REPRODUCTION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 85042880363     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M117.800755     Document Type: Article

References (42)

1. Pestka, S., Krause, C. D., and Walter, M. R. (2004) Interferons, interferonlike cytokines, and their receptors. Immunol. Rev. 202, 8-32 CrossRef Medline
2. Platanias, L. C. (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5, 375-386 CrossRef Medline
3. Tough, D. F. (2012) Modulation of T-cell function by type I interferon. Immunol. Cell Biol. 90, 492-497 CrossRef Medline
4. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., and Tough, D. F. (2001) Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461-470 CrossRef Medline
5. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., and Salazar-Mather, T. P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220 CrossRef Medline
6. Halloran, P. F., Urmson, J., Van der Meide, P. H., and Autenried, P. (1989) Regulation of MHC expression in vivo. II. IFN-α/β a inducers and recombinant IFN-α modulate MHC antigen expression in mouse tissues. J. Immunol. 142, 4241-4247 Medline
7. Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., Seya, T., and Taniguchi, T. (2003) Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. U.S.A. 100, 10872-10877 CrossRef Medline
8. Nguyen-Pham, T. N., Lim, M. S., Nguyen, T. A., Lee, Y. K., Jin, C. J., Lee, H. J., Hong, C. Y., Ahn, J. S., Yang, D. H., Kim, Y. K., Chung, I. J., Park, B. C., Kim, H. J., and Lee, J. J. (2011) Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists. Cell. Mol. Immunol. 8, 341-347CrossRef Medline
9. Hardy, M. P., Owczarek, C. M., Jermiin, L. S., Ejdebäck, M., and Hertzog, P. J. (2004) Characterization of the type I interferon locus and identification of novel genes. Genomics 84, 331-345 CrossRef Medline
10. Fung, K. Y., Mangan, N. E., Cumming, H., Horvat, J. C., Mayall, J. R., Stifter, S. A., De Weerd, N., Roisman, L. C., Rossjohn, J., Robertson, S. A., Schjenken, J. E., Parker, B., Gargett, C. E., Nguyen, H. P., Carr, D. J., et al. (2013) Interferon-ϵ protects the female reproductive tract from viral and bacterial infection. Science 339, 1088-1092 CrossRef Medline
11. Tasker, C., Subbian, S., Gao, P., Couret, J., Levine, C., Ghanny, S., Soteropoulos, P., Zhao, X., Landau, N., Lu, W., and Chang, T. L. (2016) IFN-ϵ protects primary macrophages against HIV infection. JCI Insight 1, e88255 CrossRef Medline
12. Peng, F. W., Duan, Z. J., Zheng, L. S., Xie, Z. P., Gao, H. C., Zhang, H., Li, W. P., and Hou, Y. D. (2007) Purification of recombinant human interferon- ϵ and oligonucleotide microarray analysis of interferon-ϵ-regulated genes. Protein Expr. Purif. 53, 356-362 CrossRef Medline
13. Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D., and Bairoch, A(2005) Protein identification and analysis tools on the ExPASy server, in The Proteomics Protocols Handbook (Walker, J. M., ed) pp. 571-607, Humana Press, New York
14. Jaitin, D. A., Roisman, L. C., Jaks, E., Gavutis, M., Piehler, J., Van der Heyden, J., Uze, G., and Schreiber, G. (2006) Inquiring into the differential action of interferons (IFNs): an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β. Mol. Cell. Biol. 26, 1888-1897 CrossRef Medline
15. Darnell, J. E., Jr. (1997) STATs and gene regulation. Science 277, 1630-1635 CrossRef Medline
16. Pestka, S. (2007) The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 282, 20047-20051 CrossRef Medline
17. Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G., Bertoncello, I., and Kola, I. (1995) A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons α and β and alters macrophage responses. Proc. Natl. Acad. Sci. U.S.A. 92, 11284-11288 CrossRef Medline
18. Knight, E., Jr. (1975) Heterogeneity of purified mouse interferons. J. Biol. Chem. 250, 4139-4144 Medline
19. Atzeni, F., Schena, M., Ongari, A. M., Carrabba, M., Bonara, P., Minonzio, F., and Capsoni, F. (2002) Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-γ, and IFN-α. Cell. Immunol. 220, 20-29 CrossRef Medline
20. Merigan, T. C. (1964) Purified interferons: physical properties and species specificity. Science 145, 811-813 Medline
21. Samuel, C. E., and Farris, D. A. (1977) Mechanism of interferon action. Species specificity of interferon and of the interferon-mediated inhibitor of translation from mouse, monkey, and human cells. Virology 77, 556-565 CrossRef Medline
22. Garcia-Minambres, A., Eid, S. G., Mangan, N. E., Pade, C., Lim, S. S., Matthews, A. Y., de Weerd, N. A., Hertzog, P. J., and Mak, J. (2017) Interferon ϵ promotes HIV restriction at multiple steps of viral replication. Immunol. Cell Biol. 95, 478-483 CrossRef Medline
23. Hermant, P., Francius, C., Clotman, F., and Michiels, T. (2013) IFN-ϵ is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines. PLoS One 8, e71320 CrossRef Medline
24. Yang, L., Xu, L., Li, Y., Li, J., Bi, Y., and Liu, W. (2013) Molecular and functional characterization of canine interferon-ϵ. J. Interferon Cytokine Res. 33, 760-768 CrossRef Medline
25. Karpusas, M., Nolte, M., Benton, C. B., Meier, W., Lipscomb, W. N., and Goelz, S. (1997) The crystal structure of human interferon β at 2.2-Å resolution. Proc. Natl. Acad. Sci. U.S.A. 94, 11813-11818 CrossRef Medline
26. Senda, T., Saitoh, S., and Mitsui, Y. (1995) Refined crystal structure of recombinant murine interferon-β at 2.15 Å resolution. J. Mol. Biol. 253, 187-207 CrossRef Medline
27. de Weerd, N. A., Vivian, J. P., Nguyen, T. K., Mangan, N. E., Gould, J. A., Braniff, S. J., Zaker-Tabrizi, L., Fung, K. Y., Forster, S. C., Beddoe, T., Reid, H. H., Rossjohn, J., and Hertzog, P. J. (2013) Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1. Nat. Immunol. 14, 901-907 CrossRef Medline
28. Lavoie, T. B., Kalie, E., Crisafulli-Cabatu, S., Abramovich, R., DiGioia, G., Moolchan, K., Pestka, S., and Schreiber, G. (2011) Binding and activity of all human α interferon subtypes. Cytokine 56, 282-289 CrossRef Medline
29. Jaks, E., Gavutis, M., Uzé, G., Martal, J., and Piehler, J. (2007) Differential receptor subunit affinities of type I interferons govern differential signal activation. J. Mol. Biol. 366, 525-539 CrossRef Medline
30. Yamamoto, K., Taniai, M., Torigoe, K., Yamamoto, S., Arai, N., Suemoto, Y., Yoshida, K., Okura, T., Mori, T., Fujioka, N., Tanimoto, T., Miyata, M., Ariyasu, H., Ushio, C., Fujii, M., et al. (2009) Creation of interferon-α8 (IFN-α8) mutants with amino acid substitutions against IFN-α receptor-2 (IFNAR-2)-binding sites using phage display system and evaluation of their biologic properties. J. Interferon Cytokine Res. 29, 161-170 CrossRef Medline
31. Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S., Nolan, G. P., Piehler, J., Schreiber, G., and Garcia, K. C. (2011) Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell 146, 621-632 CrossRef Medline
32. de Weerd, N. A., Matthews, A. Y., Pattie, P. R., Bourke, N. M., Lim, S. S., Vivian, J. P., Rossjohn, J., and Hertzog, P. J. (2017) A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon- β and dictates signaling. J. Biol. Chem. 292, 7554-7565 CrossRef Medline
33. Denton, P. W., and García, J. V. (2011) Humanized mouse models of HIV infection. AIDS Rev. 13, 135-148 Medline
34. Piganis, R. A., De Weerd, N. A., Gould, J. A., Schindler, C. W., Mansell, A., Nicholson, S. E., and Hertzog, P. J. (2011) Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon α receptor (IFNAR1)-associated tyrosine kinase Tyk2. J. Biol. Chem. 286, 33811-33818 CrossRef Medline
35. Stifter, S. A., Gould, J. A., Mangan, N. E., Reid, H. H., Rossjohn, J., Hertzog, P. J., and de Weerd, N. A. (2014) Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells. Protein Expr. Purif. 94, 7-14 CrossRef Medline
36. Trajanovska, S., Owczarek, C. M., Stanton, P. G., and Hertzog, P. J. (2003) Generation and characterization of recombinant unmodified and phosphorylatable murine IFN-α1 in the methylotropic yeast Pichia pastoris. J. Interferon Cytokine Res. 23, 351-358 CrossRef Medline
37. Correa, D. H. A., and Ramos, C. H. I. (2009) The use of circular dichroism spectroscopy to study protein folding, form and function. African J. Biochem. Res. 3, 164-173
38. Soares da Costa, T. P., Desbois, S., Dogovski, C., Gorman, M. A., Ketaren, N. E., Paxman, J. J., Siddiqui, T., Zammit, L. M., Abbott, B. M., Robins- Browne, R. M., Parker, M. W., Jameson, G. B., Hall, N. E., Panjikar, S., and Perugini, M. A. (2016) Structural determinants defining the allosteric inhibition of an essential antibiotic target. Structure 24, 1282-1291 CrossRef Medline
39. Christensen, J. B., Soares da Costa, T. P., Faou, P., Pearce, F. G., Panjikar, S., and Perugini, M. A. (2016) Structure and function of cyanobacterial DHDPS and DHDPR. Sci. Rep. 6, 37111 CrossRef Medline
40. Asquith, K. L., Horvat, J. C., Kaiko, G. E., Carey, A. J., Beagley, K. W., Hansbro, P. M., and Foster, P. S. (2011) Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog. 7, e1001339 CrossRef Medline
41. Montefiori, D. C. (2005) Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr. Protoc. Immunol. Chapter 12, Unit 12.11 CrossRef Medline
42. Mous, K., Jennes, W., Camara, M., Seydi, M., Daneau, G., Mboup, S., Kestens, L., and Van Ostade, X. (2012) Expression analysis of LEDGF/p75, APOBEC3G, TRIM5′, and tetherin in a Senegalese cohort of HIV-1- exposed seronegative individuals. PLoS One 7, e33934 CrossRef Medline